press review on our website at

One month after the end of the third edition of #IBSdays, here is the press review of the congress! Several newspapers talked about #IBSdays2022. Have you been to Bologna? Did you enjoy the meeting? What did you find more interesting? Let us know! #gastroenterology 👇🏽

All our wonderful lecturers in one pic!😃😃😃 #IBSdays2022 #IBSdays #congress #gastroenterology @giomara89 @esnm_eu @RomeFoundation @CarmeloSCARPIG1 @damato_mauro @VerduLab @maura_corsetti @DDrossman @drlauriekeefer @LinChangMD

With final remarks and thanks to all colleagues, partecipants and #PlanningCongressi, Prof. Giovanni Barbara closes the third succesfull edition of #IBSdays2022 in #Bologna. @esnm_eu

Best Oral Communication Awards go to Isotta Bozzarelli, Giada De Palma and Ines A Trinidade #IBSdays2022

Here we are! Best poster awards go to Leticia Camargo Tavares for a #GWAS meta-analysis, to Christian Lambiase for #IBS-C diagnosis tests, to Maria Raffaella Barbaro for a study on increased intestinal permeability in IBS-D patients. #IBSdays2022 @esnm_eu

Here is Dr. Jan Tack at #IBSdays202. Current treatment for #IBS with #diarrhoea (IBS-D) is well established. Scientific societies achieved consensus on the most useful approaches Future of #IBS-D management: “medical device”, #FODMAPs and novel pharmacological approaches

Dr.@CarmeloSCARPIG1 is reviewing studies about effective treatment for #IBS with #constipation (IBS-C). There have been important advances in #IBS-C treatments, however there are still some unmet clinical needs. New drug under investigation: #elobixibat, #olorinab #IBSdays2022

➢the role of FODMAPs in patients with #IBS ➢update of the trials’results about faecal #microbiota #transplant

Session VI is dedicated to #microbiota. Our lecturers are Dr. Premysl Bercik, Dr. Francisco Aguilar and Dr. Coleen Kelly. ➢Links between #gut #microbiota and psychiatric and neurodegenerative disorders ➢the relationships among #diet, #IBS symptoms and colonic microbiota

Is the #gut vascular barrier influenced by the #microbiota? Of course! Dr. Maria Rescigno is describing how altered microbiota, thus an altered barrier permeability, can cause microbial components to access to the systemic circulation and disseminate to other organs #IBSdays2022

#Gut #microbiota is the main responsable of the inter-individual difference among humans #IBS

Dr.Antonio Gasbarrini is giving his lecture during the session “Genetics and Barrier. The integrity of mucosal barrier and microbiota are fundamental; their disruption may contribute to the development of #metabolic and #autoimmune disorders. #IBSdays2022 #gastrointestinal

Today #IBS genetic studies are a tangible opportunity and there are research showing links between #DNA sequences and the risk of suffering from IBS. For Genetics and Barriers Session, Dr @damato_mauro is now presenting data about this interesting topic at #IBSdays2022 @esnm_eu

Dr.Collins is discussing a study to better understand if Recurrent Clostridium Difficile Infection #RCDI impact on microbiota and then on the risk of post-infectious #IBS it was also seen that diet may positively change #microbiota. #IBSdays2022 #gastroenterology #GI

Are COVID-19 patients at higher risk for #DGBI? Further data are needed to confirm what clinical experience showed so far #IBS @esnm_eu

Infection Session at #IBSdays2022 Long-COVID is a very current topic and Dr @giomara89 is discussing how SARS-CoV-2 infection may lead to persistent #GI dysfunction resembling #DGBI.

Yesterday in free poster session we spoke about #Dietary intervention in #IBS, predictive role of faecal #Collinsella aerofaciens for the Clinical efficacy #ProbioticLactobacillus Paracasei, actionable pathways relevant to #gut #Dysmotility and #IBS #IBSdays2022

Let's start the second day at #IBSdays2022! #PalazzoReEnzo #Bologna @esnm_eu

And now Free Paper Session at #IBSdays2022. See you tomorrow for the #highlights!